|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.870 USD | +4.51% |
|
+2.74% | -50.96% |
| 06-30 | Lexeo Therapeutics, Inc. - Special Call | |
| 06-17 | Lexeo Therapeutics Publishes Phase I/Ii Data for Lx2006 in Friedreich Ataxia in Jama Cardiology | CI |
| Market Cap | 382M 335M 311M 286M 539M 36.9B 547M 3.71B 1.45B 18.06B 1.44B 1.4B 62.37B | P/E 2026 * |
-4.15x | P/E 2027 * | -3.65x |
|---|---|---|---|---|---|
| Enterprise Value | 239M 210M 195M 179M 337M 23.1B 342M 2.32B 908M 11.3B 899M 879M 39.05B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 18.4x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexeo Therapeutics, Inc.
| 1 day | +4.51% | ||
| 1 week | +2.74% | ||
| Current month | +4.62% | ||
| 1 month | -3.37% | ||
| 3 months | -23.06% | ||
| 6 months | -36.59% | ||
| Current year | -50.96% |
| 1 week | 4.46 |  | 5.01 |
| 1 month | 4.33 | | 5.38 |
| Current year | 4.03 | | 10.75 |
| 1 year | 3.6 | | 10.99 |
| 3 years | 1.45 | | 22.33 |
| 5 years | 1.45 | | 22.33 |
| 10 years | 1.45 | | 22.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Townsend
CEO | Chief Executive Officer | 46 | 01/01/2020 |
Louis Tamayo
DFI | Director of Finance/CFO | 50 | 15/08/2025 |
| Chief Tech/Sci/R&D Officer | 62 | 20/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
R. Townsend
BRD | Director/Board Member | 46 | 01/01/2020 |
| Chairman | 72 | 01/01/2021 | |
Mette Agger
BRD | Director/Board Member | 61 | 01/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 A | Sell | Chief Executive Officer | -25,947 | 0.0330% | ||
| 7/1/26 A | Sell | Chief Operating Officer | -4,666 | 0.0059% | ||
| 7/1/26 A | Sell | Chief Financial Officer | -4,641 | 0.0059% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.51% | +2.74% | +25.19% | - | 382M | |
| -0.43% | -4.26% | +52.09% | +85.69% | 55.27B | |
| +3.53% | +4.48% | +60.45% | +63.67% | 54.15B | |
| -1.82% | -2.89% | +3.61% | +405.88% | 23.11B | |
| -0.54% | -0.17% | -17.60% | -15.43% | 23.22B | |
| +1.03% | -0.20% | +36.49% | -3.23% | 20.33B | |
| -1.44% | -0.42% | +29.87% | -30.12% | 17.91B | |
| +0.87% | -0.19% | +39.07% | +553.51% | 15.76B | |
| +0.43% | -10.61% | +175.63% | +299.61% | 15B | |
| -2.03% | -1.03% | +23.63% | +179.23% | 13.82B | |
| Average | +0.40% | -1.21% | +42.84% | +170.98% | 23.9B | |
| Weighted average by Cap. | +0.39% | -1.05% | +44.74% | +135.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.11M 5.35M 4.97M 4.57M 8.61M 590M 8.73M 59.22M 23.18M 289M 22.94M 22.45M 997M |
| Net income | -97.88M -85.76M -79.62M -73.16M -138M -9.44B -140M -948M -371M -4.62B -367M -360M -15.96B | -123M -108M -100M -92.03M -173M -11.88B -176M -1.19B -467M -5.81B -462M -452M -20.08B |
| Net Debt | -143M -125M -116M -107M -201M -13.8B -204M -1.39B -542M -6.75B -537M -525M -23.32B | -270M -236M -219M -202M -380M -26.02B -385M -2.61B -1.02B -12.73B -1.01B -991M -43.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | $4.870 | +4.51% | 4,657,422 |
| 21/07/26 | $4.660 | +2.42% | 331,121 |
| 20/07/26 | $4.550 | -2.99% | 414,958 |
| 17/07/26 | $4.690 | +2.85% | 730,135 |
| 16/07/26 | $4.560 | -3.80% | 780,226 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXEO Stock
Select your edition
All financial news and data tailored to specific country editions
